PerkinElmer, Inc.  

(Public, NYSE:PKI)   Watch this stock  
Find more results for Custom Living, Inc
47.15
-0.23 (-0.49%)
Jul 29 - Close
NYSE real-time data - Disclaimer
Currency in USD
Range 47.08 - 47.52
52 week 33.93 - 48.26
Open 47.39
Vol / Avg. 658,119.00/606,501.00
Mkt cap 5.34B
P/E 31.44
Div/yield 0.07/0.59
EPS 1.50
Shares 113.22M
Beta 0.90
Inst. own 95%
Jul 31, 2014
Q2 2014 PerkinElmer Inc Earnings Call - 5:00PM EDT - Add to calendar
Jul 31, 2014
Q2 2014 PerkinElmer Earnings Release - 4:00PM EDT - Add to calendar
Jun 10, 2014
PerkinElmer at Goldman Sachs Healthcare Conference
May 15, 2014
PerkinElmer at Bank of America Merrill Lynch Health Care Conference
May 7, 2014
PerkinElmer at Robert W. Baird & Co. Inc Growth Stock Conference
More events from DailyFinance »    

Key stats and ratios

Q1 (Mar '14) 2013
Net profit margin 6.45% 7.75%
Operating margin 9.54% 10.04%
EBITD margin - 17.62%
Return on average assets 3.48% 4.28%
Return on average equity 6.84% 8.54%
Employees 7,600 -
CDP Score - 62 D

Address

940 WINTER STREET
WALTHAM, MA 2451
United States - Map
+1-781-6635776 (Phone)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

PerkinElmer, Inc. is a provider of products, services and solutions to the diagnostics, research, environmental, industrial and laboratory services markets. Through the Company�s advanced technologies, solutions, and services, it addresses issues related to health and safety of people and their environment. It operates in two segments: Human Health and Environmental Health. The Company�s Human Health segment concentrates on developing diagnostics, tools and applications to help detect diseases earlier and accelerate the discovery and development of critical new therapies. The Company�s Environmental Health segment provides technologies and applications to facilitate the creation of safer food and consumer products, secure surroundings and energy resources.

Officers and directors

Robert F. Friel Chairman of the Board, President, Chief Executive Officer
Age: 58
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Frank Anders Wilson CPA Chief Financial Officer, Senior Vice President
Age: 55
Bio & Compensation  - Reuters
Daniel R. Marshak Ph.D. Chief Scientific Officer, Senior Vice President, President - Emerging Diagnostics
Age: 56
Bio & Compensation  - Reuters
Joel S. Goldberg Senior Vice President, General Counsel, Secretary
Age: 45
Bio & Compensation  - Reuters
John R. Letcher Senior Vice President - Human Resources
Age: 52
Bio & Compensation  - Reuters
James L. Corbett Senior Vice President, President - Diagnostics
Age: 51
Bio & Compensation  - Reuters
Jon DiVincenzo Senior Vice President, President - Environmental Health
Bio & Compensation  - Reuters
Maurice H. Tenney III Senior Vice President, President - Global Operations and Customer Logistics
Age: 50
Bio & Compensation  - Reuters
Andrew Okun Chief Accounting Officer, Vice President
Age: 44
Bio & Compensation  - Reuters
Nicholas A. Lopardo Lead Independent Director
Age: 67
Bio & Compensation  - Reuters